In a filing, ANI Pharmaceuticals Inc revealed its SR. VP, GENERAL COUNSEL & SEC. Cook Meredith unloaded Company’s shares for reported $14298.0 on Oct 14 ’24. In the deal valued at $57.19 per share,250 shares were sold. As a result of this transaction, Cook Meredith now holds 56,488 shares worth roughly $3.16 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Cook Meredith sold 250 shares, generating $14,205 in total proceeds. Upon selling the shares at $56.82, the SR. VP, GENERAL COUNSEL & SEC. now owns 56,738 shares.
Before that, Cook Meredith sold 250 shares. ANI Pharmaceuticals Inc shares valued at $14,905 were divested by the SR. VP, GENERAL COUNSEL & SEC. at a price of $59.62 per share. As a result of the transaction, Cook Meredith now holds 56,988 shares, worth roughly $3.19 million.
Piper Sandler initiated its ANI Pharmaceuticals Inc [ANIP] rating to an Overweight in a research note published on October 11, 2024; the price target was $68. A number of analysts have revised their coverage, including CapitalOne’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. H.C. Wainwright also remained covering ANIP and reiterated its “Buy” recommendation on August 22, 2023. Guggenheim started covering the stock on March 01, 2023. It rated ANIP as “a Buy”.
Price Performance Review of ANIP
On Monday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock fall -3.75% to $56.01. Over the last five days, the stock has lost -3.37%. ANI Pharmaceuticals Inc shares have risen nearly 1.58% since the year began. Nevertheless, the stocks have fallen -10.47% over the past one year. While a 52-week high of $70.81 was reached on 03/25/24, a 52-week low of $48.20 was recorded on 09/11/24. SMA at 50 days reached $58.98, while 200 days put it at $62.00.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 55.19, which if violated will result in even more drops to 54.37. On the upside, there is a resistance level at 57.44. A further resistance level may holdings at 58.87. The Relative Strength Index (RSI) on the 14-day chart is 40.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.64, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.07%. Stochastics %K at 11.19% indicates the stock is a buying.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2024-10-15, dropping by -0.17 million shares to a total of 2.05 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 2.22 million shares. There was a decline of -8.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 07, 2022 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
